Sallie Mae remains a leading private student loan provider, growing originations nearly 10% YoY and capturing 60% market ...

This article explores how challenges such as sequence optimization, immune activation and off-target effects are being ...

Mevolaxy posts record November results with all-time-high user earnings, rapid growth, and $4M funding from Helios Capital.

Are you or your client considering writing third party (re)insurance business within a Cayman Segregated Portfolio Company insurer (SPC) and ...

Here & Now’s Rob Schmitz spoke to STAT health reporter Katie Palmer about the evolution of telehealth, the consumerization of medicine and how the model could drive up health care costs overall.

Feedback from U.S. Food and Drug Administration (FDA) supports advancement into a pivotal Phase 3 trial and a 505(b)(2) regulatory pathway Phase 3 SURPASS-IPF trial remains on track to be initiated by ...

Discover why Kodiak AI, Inc. is a Buy for early autonomous trucking exposure. Learn about their growth, valuation, and market ...

This paper aims to critique the argument constructed by Anna Smajdor and Joona Räsänen that pregnancy is a disease. Their argument that pregnancy fits the features of disease they enumerate stems from ...

RAISE focuses on improving race and ethnicity data collection to address healthcare disparities and unmet medical needs. The ...

College football is in a bad state, affecting many programs, including North Carolina.

ENIGMA-TRS 2 is a global, randomized, double-blind, placebo-controlled 12-week Phase III clinical study designed to enroll at least 400 patients; topline results are expected by Q4 2026Evenamide is a ...